Albireo Pharma Inc (NASDAQ:ALBO)

24.51
Delayed Data
As of 4:00pm ET
 -0.41 / -1.65%
Today’s Change
16.13
Today|||52-Week Range
38.69
-3.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$370.7M

Company Description

Albireo Pharma, Inc. is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its product pipeline includes A4250, Elobixibat, and A3384. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Contact Information

Albireo Pharma, Inc.
10 Post Office Square
Boston Massachusetts 02109
P:(857) 254-5555
Investor Relations:

Employees

Shareholders

Other institutional36.22%
Mutual fund holders35.97%
Individual stakeholders29.00%

Top Executives

There are no executives to display.